RegenoCELL Therapeutics, Inc.
company.status.inactiveCIK 1221749fmd_03AKZSNXZRVQ7N2TVCSJK9C3Z1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Dec 31, 2011, 6 periods
Latest annual · FY2011
Millions- Total revenues
- 1
- Gross profit
- 1
- Operating income
- (1)
- Net income
- (1)
Latest quarter · Q4 FY2011
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
- Free cash flow
- (0)
RegenoCELL Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2011 | FY2010 | Change | Source |
|---|---|---|---|---|
| Revenue | $865,020 | $910,048 | -4.9% | 10-K 2012-05-25 · proof |
| Gross profit | $737,902 | $817,637 | -9.8% | 10-K 2012-05-25 · proof |
| Operating income | -$862,874 | -$3.6 million | 10-K 2012-05-25 · proof | |
| Net income | -$1.3 million | -$3.8 million | 10-K 2012-05-25 · proof | |
| Cash from operating activities | -$317,457 | -$177,408 | 10-K 2012-05-25 · proof | |
| Total assets | $247,432 | $342,432 | -27.7% | 10-K 2012-05-25 · proof |
| Total liabilities | $5.7 million | $4.4 million | +28.2% | 10-K 2012-05-25 · proof |
| Cash and cash equivalents | $11,054 | $3,436 | +221.7% | 10-K 2012-05-25 · proof |
- What was RegenoCELL Therapeutics, Inc.'s revenue in fiscal 2011?
- RegenoCELL Therapeutics, Inc. reported revenue of $865,020 for fiscal 2011 (the year ended Dec 31, 2011), against $910,048 the year before (-4.9%). Source: the 10-K filed with the SEC on May 25, 2012. SEC
- What was RegenoCELL Therapeutics, Inc.'s gross profit in fiscal 2011?
- RegenoCELL Therapeutics, Inc. reported gross profit of $737,902 for fiscal 2011 (the year ended Dec 31, 2011), against $817,637 the year before (-9.8%). Source: the 10-K filed with the SEC on May 25, 2012. SEC
- What was RegenoCELL Therapeutics, Inc.'s operating income in fiscal 2011?
- RegenoCELL Therapeutics, Inc. reported operating income of -$862,874 for fiscal 2011 (the year ended Dec 31, 2011), against -$3.6 million the year before. Source: the 10-K filed with the SEC on May 25, 2012. SEC
- What was RegenoCELL Therapeutics, Inc.'s net income in fiscal 2011?
- RegenoCELL Therapeutics, Inc. reported net income of -$1.3 million for fiscal 2011 (the year ended Dec 31, 2011), against -$3.8 million the year before. Source: the 10-K filed with the SEC on May 25, 2012. SEC
- What was RegenoCELL Therapeutics, Inc.'s cash from operating activities in fiscal 2011?
- RegenoCELL Therapeutics, Inc. reported cash from operating activities of -$317,457 for fiscal 2011 (the year ended Dec 31, 2011), against -$177,408 the year before. Source: the 10-K filed with the SEC on May 25, 2012. SEC
- What are RegenoCELL Therapeutics, Inc.'s total assets?
- As of Dec 31, 2011, RegenoCELL Therapeutics, Inc. reported total assets of $247,432, against $342,432 a year earlier (-27.7%). Source: the 10-K filed with the SEC on May 25, 2012. SEC
- What are RegenoCELL Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2011, RegenoCELL Therapeutics, Inc. reported total liabilities of $5.7 million, against $4.4 million a year earlier (+28.2%). Source: the 10-K filed with the SEC on May 25, 2012. SEC
- What are RegenoCELL Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2011, RegenoCELL Therapeutics, Inc. reported cash and cash equivalents of $11,054, against $3,436 a year earlier (+221.7%). Source: the 10-K filed with the SEC on May 25, 2012. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1221749&period_type=annual&limit=5"Information only, not investment advice.